Quoin Pharmaceuticals (QNRX)
(Delayed Data from NSDQ)
$0.78 USD
+0.08 (10.86%)
Updated May 31, 2024 03:50 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | -0.75 |
EPS Last Quarter | -1.11 |
Last EPS Surprise | NA |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.79 |
Next Year | NA |
EPS (TTM) | -7.27 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.75 | -0.57 | -2.79 | NA |
# of Estimates | 1 | 1 | 1 | NA |
Most Recent Consensus | -0.75 | -0.57 | -2.79 | NA |
High Estimate | -0.75 | -0.57 | -2.79 | NA |
Low Estimate | -0.75 | -0.57 | -2.79 | NA |
Year ago EPS | -2.13 | -1.95 | -9.64 | -2.79 |
Year over Year Growth Est. | 64.79% | 70.77% | 71.06% | NA |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | NA |
Up Last 30 Days | 0 | 0 | 1 | NA |
Up Last 60 Days | 0 | 0 | 1 | NA |
Down Last 7 Days | 0 | 0 | 0 | NA |
Down Last 30 Days | 0 | 0 | 0 | NA |
Down Last 60 Days | 0 | 0 | 0 | NA |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.75 | -0.57 | -2.79 | NA |
7 Days Ago | -0.75 | -0.57 | -2.79 | NA |
30 Days Ago | NA | NA | -9.36 | NA |
60 Days Ago | NA | NA | -9.36 | NA |
90 Days Ago | NA | NA | -9.36 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.75 | -0.57 | -2.79 | NA |
Zacks Consensus Estimate | -0.75 | -0.57 | -2.79 | NA |
Earnings ESP | 0.00% | 0.00% | 0.00% | NA |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.11 | -2.08 | -1.95 | -2.13 | NA |
Estimate | NA | -2.37 | -2.40 | NA | NA |
Difference | NA | 0.29 | 0.45 | NA | 0.37 |
Surprise | NA | 12.24% | 18.75% | NA | 15.50% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more